O.2Growth differentiation factor 15 is a valuable biomarker of therapeutic response for TK2 deficient myopathy

Authors :: I. Martí
M. Madruga-Garrido
Andrés Nascimento
M. A. Martín
F. Mavillard Saborido
Carmen Badosa
Susana G. Kalko
C. Jimenez-Mallebrera
Carlos Ortez
J. Diaz-Manera
Yolanda Cámara
Ramon Martí
R. Montero
Cristina Domínguez-González
Carmen Paradas
R. Artuch
C. Blázquez-Bermejo
E. Martín-Hernández
Source :: Neuromuscular Disorders. 29:S38
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Neurology
business.industry
Pediatrics, Perinatology and Child Health
Cancer research
medicine
Biomarker (medicine)
Neurology (clinical)
medicine.symptom
Myopathy
business
Genetics (clinical)

Full Text Access

Tools